Orthogon Therapeutics is an Angel backed, pre-clinical stage start up developing a pipeline of therapeutics in a range of disease indications with significant unmet medical need.
Location: United States, Massachusetts, Canton
Employees: 1-10
Total raised: $14M
Investors 1
| Date | Name | Website |
| - | Startup Le... | startuplea... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 24.07.2023 | - | $6M | - |
| 08.11.2021 | - | $8M | - |
Mentions in press and media 7
| Date | Title | Description |
| 24.07.2023 | Orthogon Therapeutics Celebrates Major Technical Milestone and Secures Additional $6M Toward a Pioneering Drug for BK Virus | The Company announced the development of the first antiviral to combat BK virus, one of the most common viral infections in transplant patients CANTON, Mass.–(BUSINESS WIRE)–July 24, 2023– Orthogon Therapeutics LLC, a trailblazer in the fie... |
| 11.03.2022 | New Communication Between Science and Business Promotes Growth in Both Sectors | David Thompson, Tech Times 11 March 2022, 11:03 am (Photo : Dr. Ali H. Munawar) The COVID-19 pandemic has presented disruption in numerous sectors, and scientific research has been subject to public scrutiny on a new scale. The public is hu... |
| 24.02.2022 | How Leaders Can Support The Scientific Community By Advocating Accurate Information Sharing | Health — personal practices, information sharing, and more — has become a category by which leaders are judged. Beyond the PR component, leaders recognize that their ability to effectively manage an organization requires them to streamline ... |
| 15.11.2021 | Former Novartis Executive Dr. Marie Lindner Joins Orthogon Therapeutics’ Board of Directors | Dr. Lindner Brings Experience in Venture Capital and Strategic Partnerships CANTON, Mass.–(BUSINESS WIRE)–November 15, 2021– Orthogon Therapeutics LLC, a drug development company focused on designing innovative antivirals and anti-infective... |
| 08.11.2021 | Orthogon Therapeutics Announces an $8M Follow-On Financing to Advance Its Lead BK Virus Drug | Orthogon Therapeutics LLC, a drug development company focused on designing innovative antivirals and anti-infective therapeutics, announced that it has raised an $8M round from a leading syndicate of US based healthcare Angels to advance it... |
| 08.11.2021 | Orthogon Therapeutics Announces an $8m Follow-On Financing to Advance Its Lead BK Virus Drug | The Company is developing the first, orally available antiviral to treat one of the most common viral infections in pediatric and adult transplant patients CANTON, Mass.–(BUSINESS WIRE)–November 8, 2021– Orthogon Therapeutics LLC, a drug de... |
| 08.11.2021 | Orthogon Therapeutics Raises $8M Follow-On Financing | Orthogon Therapeutics LLC, a Canton, Mass.-based drug development company focused on designing innovative antivirals and anti-infective therapeutics, raised an additional $8m funding round. A syndicate of US based healthcare angels particip... |